Recherche avancée
Instruments
Nom | Mnemo | Place boursière | Volume moyen | Cours | Type | |
---|---|---|---|---|---|---|
ELISA OYJ | ELISA | Nasdaq Helsinki +6 Autres | 300 553 | 42,88 EUR | Action | |
ELISA OYJ | EIA | Deutsche Boerse AG | 67 | 42,66 EUR | ||
ELISA OYJ | 0I8Y | London S.E. | - | 42,65 EUR | ||
ELISA OYJ | EIA | Börse Stuttgart | - | 42,76 EUR | ||
ELISA OYJ | EIA | BOERSE MUENCHEN | 51 | 42,98 EUR | ||
ELISA OYJ | ELMUF | OTC Markets | 1 631 | 45,16 USD | ||
ELISA OYJ | EIA | Berne S.E. | - | - CHF | ||
ELISA OYJ | ELMUY | OTC Markets | 402 | 23,25 USD | Action | |
ELISA OYJ (EI6) - ELA/C5 | Euronext Amsterdam | - | 42,6 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C6 | Euronext Amsterdam | - | 42,96 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C2 | Euronext Amsterdam | - | 43,03 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20241220 | Euronext Amsterdam | - | 42,6 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C1 | Euronext Amsterdam | - | 42,89 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C3 | Euronext Amsterdam | - | 43,16 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C4 | Euronext Amsterdam | - | 43,32 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20240620 | Euronext Amsterdam | - | 42,89 EUR | Future |
Profils Sociétés (17)
Beijing Wantai Biopharmaceutical Co. est une société principalement engagée dans la recherche et le développement, la production et la vente de diagnostics in-vitro. La société produit et vend des diagnostics in vitro, des équipements de diagnostic in vit ...
Elisa Oyj est le 1er opérateur de télécommunications finlandais. Le CA par activité se répartit comme suit : - téléphonie mobile (59,2%) ; - prestations de télécommunications fixes (40,8%) : prestations de téléphonie fixe et d'accès à l'Internet haut dé ...
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS est une entreprise basée en Turquie qui se consacre à la recherche, au développement et à la production de diagnostics in vitro. Ses produits de diagnostic comprennent : Microbiologie ...
Bioporto A/S est une société danoise qui développe et commercialise des tests de diagnostic in vitro (DIV). Le portefeuille de la société comprend cinq catégories de produits : Le test NGAL (Neutrophil gelatinase-associated lipocalin), qui permet de diagn ...
Soprocal Calerias e Industrias SA est une société chilienne engagée dans l'acquisition et l'exploitation de gisements minéraux ainsi que dans la production de carbonate de calcium, de chaux vive, de chaux off, de chaux hydraulique, ainsi que d'autres déri ...
Quanterix Corporation est une société spécialisée dans les sciences de la vie. La société développe des plateformes d'immunoessais numériques ultra-sensibles qui font progresser la santé de précision pour la recherche et le diagnostic dans le domaine des ...
AroCell publ AB est une société de diagnostic basée en Suède qui développe des marqueurs pour la détermination de la croissance cellulaire (TK 210) et de l'apoptose. Le principal produit candidat de la société, TK-immuno/hem, est un test de surveillance e ...
Cheilbio Co. est une société coréenne spécialisée dans la fabrication de médicaments vétérinaires. La société propose des antibiotiques, des antimicrobiens, des lactobacilles, des préparations enzymatiques, des parasiticides, des antiseptiques, des oligo- ...
American Vietnamese Biotech Incorporation (AmviBiotech) est une entreprise vietnamienne active dans l'industrie pharmaceutique. La société fabrique des médicaments, des vaccins et des produits biologiques. Elle est également impliquée dans la fabrication ...
Bioventix plc est une société britannique spécialisée dans le développement et la commercialisation d'anticorps monoclonaux à haute affinité pour des applications dans le domaine du diagnostic clinique, telles que les immunodosages automatisés utilisés da ...
Shenzhen Bioeasy Biotechnology Co Ltd est une société chinoise qui se consacre principalement à la recherche, au développement, à la production, à la vente et à la fourniture de produits d'analyse de la sécurité alimentaire et de services connexes. Les pr ...
Aptamer Group plc est une société basée au Royaume-Uni qui développe des liants d'affinité sur mesure grâce à sa plateforme Optimer afin de permettre de nouvelles approches dans les domaines de la thérapeutique, du diagnostic et de la recherche. La platef ...
ViroGates A/S est une entreprise de technologie médicale basée au Danemark. Elle développe une ligne de produits suPARnostic, qui mesure la quantité de protéine soluble urokinase Plasminogen Activator Receptor (suPAR) dans le sang humain. Le niveau de pla ...
Spring Art Holdings Berhad est une société holding d'investissement basée en Malaisie. La société, par l'intermédiaire de sa filiale Spring Art Industries Sdn. Bhd. est principalement impliquée dans la fabrication de produits d'ameublement prêts à assembl ...
Bioqual, Inc. est engagé dans la prestation de services de recherche sous contrat, qui se concentrent sur les modèles in vivo de maladies humaines, y compris le COVID-19, le syndrome d'immunodéficience acquise (SIDA), la grippe, la Mpox, l'infection par l ...
Diadexus, Inc. est une société de diagnostic. La société développe et commercialise des produits qui fournissent aux prestataires de soins de santé des informations pertinentes pour faciliter la prise en charge des patients tout au long de l'évolution de ...
Techlab Inc. (Techlab) est un fabricant d'appareils médicaux de diagnostic. La société développe et fabrique des diagnostics intestinaux dans le monde entier. Techlab fabrique une variété de diagnostics entériques in vitro pour déterminer Clostridium diff ...
Insiders
Elisa Patrizi occupe actuellement le poste de responsable des opérations et de la maintenance chez Infrastrutture Wireless Italiane SpA. Auparavant, Mme Patrizi était directrice du développement sans fil chez Telecom Italia SpA. Elle est titulaire d'un diplôme de premier cycle de l'Universit degli Studi di Roma Tor Vergata.
Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.
Marco Anselmo Patrizi currently works at Morison KSi Ltd., as Director.
Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.
Elisa J.
Hamill is the founder who founded LifeHealth LLC (Colorado) in 2004, where she currently holds the title of Managing Partner.
She previously worked as Vice President-Operations at RMD Networks, Inc.
Elisa Mojica currently works at Family Health Center of Worcester, Inc., as Director-Patient Accounts.
Elisa Lee worked as an Attorney at Latham & Watkins LLP from 2000 to 2008.
She then worked as Senior Counsel at The Cooper Cos., Inc. in 2008 and as Assistant General Counsel at CooperVision, Inc. in 2009.
From 2009 to 2014, she worked at ICE Mortgage Technology, Inc. as Secretary, Executive VP & General Counsel.
She also worked as Secretary & Chief Legal Officer at Plex Systems, Inc. Ms. Lee holds an undergraduate degree from the University of California, Berkeley and a graduate degree from New York University.
Elisa M.
Corra currently works at New Life Solution, Inc., as Senior Vice President-Operations.
Ms. Corra also formerly worked at Pitney Bowes, Inc., as Principal, PSEG Energy Technologies, Inc., as Principal, ATI Telecom International Ltd., as Principal, The Robert Allen Group, Inc., as Principal, Imagitas, Inc., as Senior Vice President-Operations, and Burns & Roe Group, Inc., as Principal.
Ms. Corra received her graduate degree from Stevens Institute of Technology and undergraduate degree from Manhattan College.
Elisa Corghi is currently an Independent Director at Recordati SpA.
She also holds director positions at Nexi Payments SpA, Nexi SpA, Pitti Immagine Srl, Corneliani SpA, and RE Valuta SpA.
Previously, she served as an Independent Director at BasicNet SpA and Tinexta SpA.
Ms. Corghi's former roles include Senior Brand Manager-Sottilette Kraft at Mondelez International, Inc., Analyst at Intermonte Sim SpA, and Brand Manager at Barilla Alimentare SpA.
She obtained her undergraduate degree from the University of Bocconi in 1996.
Elisa Nardi worked as a Managing Director-People at Virgin Media, Inc. and as a Chief People Officer at The British United Provident Association Ltd.
Elisa Hebb is currently the EVP-Clinical Development & Regulatory Affairs at Endologix LLC since 2018.
Prior to this, she held the position of Vice President-Clinical & Regulatory Affairs at Crux Biomedical, Inc. starting in 2008 and Vice President-Clinical Affairs at Apneon, Inc. starting in 2007.
Ms. Hebb's former positions include Director-Clinical Programs at Boston Scientific Corp., Senior Director-Global Clinical Affairs at Philips Image Guided Therapy Corp.
from 2014 to 2015, and Senior Director-Clinical Affairs at Wallace Enterprises, Inc. Ms. Hebb completed her undergraduate degree at the University of California, Berkeley.
Elisa Bruce has worked as a Vice President at Fifth Third Bank, NA in Cincinnati, Ohio.
Elisa Lumbantoruan is currently serving as an Independent Commissioner at PT Indosat Tbk since 2022.
Previously, he held the position of President Director & Chief Executive Officer at PT ISS Indonesia and PT ISS Facility Services from 2015 to 2023.
He also served as Executive VP, Director-Marketing & Sales at PT Garuda Indonesia (Persero) Tbk from 2012 to 2013.
Mr. Lumbantoruan has a strong background in leadership roles, having served as President Director at PT Hewlett-Packard Indonesia from 2002 to 2007.
He has also held various managerial positions at PT XL Axiata Tbk, PT Astra Graphia Tbk, and PT Cipta Arta Graha Informasi.
Mr. Lumbantoruan's educational background includes an undergraduate degree from Institut Teknologi Bandung, which he obtained in 1985.
Ms. Elisa Schupp is a Vice President-Channels & Strategic Sales at CNW Group Ltd.
Ms. Schupp also served on the board at Canadian Investor Relations Institute.
Elisa Freeman worked as a Senior Vice President-Distribution Operations at Discovery, Inc.
Elisa Belgacem worked as a Quantitative Researcher at Crédit Agricole Corporate & Investment Bank SA from 2013 to 2019.
She also worked as a Strategist at Crédit Agricole Cheuvreux SA.
Elisa Crotti is currently a Partner at RNT Invest Srl, Ticinese Building Srl, and Moffu Labs 2 Srl.
Previously, she worked as an Independent Director at SECO SpA, a Principal at The Boston Consulting Group, Inc., and an EVP-Strategy & Business Development at The Nuance Group AG.
Ms. Crotti holds an MBA from INSEAD and an undergraduate degree from Politecnico di Milano (conferral date: 1998).
Elisa LeNoir
CHIEF COMPLIANCE OFFICER
Elisa is the Chief Compliance Officer at Lead Edge Capital.
Prior to joining Lead Edge, she was the Compliance Associate at JANA Partners LLC, an investment manager focusing on event-driven investing.
Elisa received her B.S.
in Psychology from the University of Florida, and her M.A.
in International Psychology from The Chicago School of Professional Psychology.
Elisa Manassa has a current job as the Head-Accounting at Yolo Group SpA.
Elisa Valeriani has a current job as an Independent Director at BPER Banca SpA.
Elisa Wever currently works as a Secretary & Director for the Society of St. Vincent de Paul Toronto Central Council.
Elisa Heslop currently works at Greenwich House, Inc., as Director from 2017.
Elisa Landers currently works as a Director at Boys & Girls Clubs of Portland.
Elisa Denise Turcot has worked as a Secretary at Green Mining Innovation, Inc. since 2023.
Elisa Baroncini is currently an Independent Non-Executive Director at Eni SpA.
She is also a Professor of International Law at Alma Mater Studiorum - Università di Bologna and a Member at World Investment Srl.
Previously, she served as the Co-Chairman of International Economic Law at the European Society of International Law from 2012 to 2022.
Elisa Janine Nasho currently works at Aviva Central Services UK Ltd., as Director from 2023.
Ms. Elisa A.
Mazen is a Managing Director, Head of Global Growth & Portfolio Manager at ClearBridge Investments LLC and at ClearBridge LLC.
In ClearBridge LLC, she is the head of firm's Global Growth Equity investment team and co-manages numerous global and international growth strategies.
In ClearBridge she is responsible for covering the consumer sector for firm's international and global growth portfolios.
She has over 39 years of investment industry experience.
Ms. Mazen joined ClearBridge from predecessor firm Global Currents Investment Management, which was founded in 2008 by a group of portfolio managers from Brandywine Global Investment Management.
Prior to joining Global Currents, she was a Managing Director and Head of the International and Global Equity Investments Group at Oppenheimer Capital, a division of Allianz Global Investors.
In addition, she was Executive Vice President and Portfolio Manager for the Central European Value Fund and had responsibility for a number of other funds at the firm.
Prior to Oppenheimer, she was a portfolio manager at Clemente Capital where she managed assets for public pension funds.
She began her career at Mitchell Hutchins Asset Management, now a subsidiary of UBS, in the High Yield investment area.
Ms. Mazen received her BA in Economics and Finance from Douglass College, Rutgers University.
Elisa Avagnina has a current job as a Director at Acquedotto Langhe e Alpi Cuneesi SpA.
Elisa O.
Abalajon is currently the Chief Human Resources Officer at Universal Robina Corp.
Her former job was as HR Director-Southeast Asia at Mondelez International AMEA Pte Ltd.
She received her undergraduate degree from Singapore Management University in 2013 and also attended Ateneo De Manila Law School for undergraduate studies.
Elisa Vall is currently a Director at Egis Group.
She previously worked as a Director at Egis SA.
Elisa D'Amico is associated with Fendi Srl as an Ethics & Compliance Officer since 2020.
She is also a Member-Supervisory Body at Fendi Italia Srl.
Aucun résultat pour cette recherche
- Bourse
- Recherche avancée
- Elisa Patrizi